RET-Positive Metastatic NSCLC


WCLC 2022 on the Phase II DOLPHIN Study: Durvalumab + Concurrent RT in Unresectable Locally Advanced NSCLC

73 views
August 29, 2022
Comments 0
Login to view comments. Click here to Login